财务信息 - 프로스테믹스
 
 

Balance Sheet - Settlement

Finance Label 2017 2016 2015
Price Composition Increase Price Composition Increase Price Composition Increase
total current assets 19,238 47% 33.8% 29,069 61.8% 0.9% 29,322 68.2% 279.5%
total non-current assets 21,699 53% 20.9% 17,948 38.2% 31.5% 13,648 31.8% 110.9%
total assets 40,937 100% 12.9% 47,017 100% 9.4% 42,969 100% 202.7%
total current liabilities 1,061 2.6% 41.3% 1,808 3.8% 41.6% 1,277 3% 85.2%
total non-current liabilities 234 .6% 7% 219 .5% 91% 2,421 5.6% 11.8%
total liabilities 1,295 3.2% 36.1% 2,027 4.3% 45.2% 3,699 8.6% 7.7%
capital stocks 4,517 11% 0% 4,517 9.6% 4.1% 4,339 10.1% 21.1%
capital surplus 7,971 19.5% 75.8% 32,971 70.1% 20.1% 41,246 96% 916.2%
retained earnings 26,705 65.2% 498.6% 4,461 9.5% 145.9% -9,716 -22.6% 680.1%
total stockholders' equity 39,642 96.8% 11.9% 44,990 95.7% 14.6% 39,271 91.4% 264.9%

Income Statement - Settlement

Finance Label 2017 2016 2015
Price Composition Increase Price Composition Increase Price Composition Increase
sales(net) 6,022 100% 57.8% 14,283 100% 2.1% 14,597 100% 45.7%
gross profit 3,540 58.8% 67.7% 10,965 76.8% 8% 11,924 81.7% 85.2%
operating income -4,140 -68.7% 194.6% 4,375 30.6% 29.6% 6,213 42.6% 80.3%
non-operating income 467 7.8% 62.4% 1,241 8.7% 145.8% 505 3.5% 415.6%
non-operating expenses 645 10.7% 12.8% 572 4% 96% 14,256 97.7% 4389.7%
net income -2,892 -48% 164.2% 4,507 31.6% 154% -8,344 -57.2% 407.5%

Cash Flow Statement - Settlement

Finance Label 2017 2016 2015
Price Increase Price Increase Price Increase
cash flows from operating activities -3,174 150.8% 6,253 7.8% 5,801 22.1%
cash flows from investing activities 8,778 199.3% -8,839 79.5% -4,925 144.8%
cf from financing act. -3,307 0% 0 0% -254 115%
increases(decreases) in cash 2,297 188.8% -2,586 516.4% 621 86%
cash at the beginning of the period 3,495 41% 5,924 15.9% 5,111 662.3%
cash at the end of the period 5,668 62.2% 3,495 41% 5,924 15.9%
简体中文